Medpace Holdings, Inc.
MEDP · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $15 | $9 | $9 | $10 |
| - Cash | $0 | $0 | $0 | $1 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $15 | $9 | $9 | $10 |
| Revenue | $1 | $1 | $1 | $1 |
| % Growth | 9.4% | 8% | 4.1% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 29.8% | 29.8% | 31.9% | 33.2% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 22.7% | 19.5% | 21.6% | 24.8% |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 16.8% | 15% | 20.5% | 21.8% |
| EPS Diluted | 3.87 | 3.1 | 3.67 | 3.67 |
| % Growth | 24.8% | -15.5% | 0% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | $0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |